These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1841843)

  • 1. Effects of oral contraceptive on fibrinogen levels in African women.
    Famodu AA; Ehigiegba AE; Fakoya TA; Adeyi J; Diejomach FM
    Haematologia (Budap); 1991; 24(3):135-8. PubMed ID: 1841843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic activity in women on oral contraceptive pills: variation due to haemoglobin genotype.
    Famodu AA; Erhunmwunse RU; Elom EU
    Acta Trop; 1992 Dec; 52(2-3):135-8. PubMed ID: 1363177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased blood viscosity in young women using oral contraceptives.
    Lowe GD; Drummond MM; Forbes CD; Barbenel JC
    Am J Obstet Gynecol; 1980 Aug; 137(7):840-2. PubMed ID: 6967698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epidemiological study of the haemostatic and other effects of oral contraceptives.
    Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
    Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostatic changes and the oral contraceptive pill.
    Norris LA; Bonnar J
    Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):545-64. PubMed ID: 9488791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation studies in women using combination type of oral contraceptives.
    Sharma S; Sharma M; Soni IJ; Gupta A; Jain R
    J Obstet Gynaecol India; 1983 Aug; 33(4):519-24. PubMed ID: 12339832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive choices in women with coagulation disorders.
    Comp PC; Zacur HA
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy.
    Lee AJ; Lowe GD; Smith WC; Tunstall-Pedoe H
    Br J Haematol; 1993 Apr; 83(4):616-21. PubMed ID: 8518178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
    Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
    Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive agents.
    Shearman RP
    Med J Aust; 1986 Feb; 144(4):201-5. PubMed ID: 3945219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorheological effects of oral contraceptives.
    Ernst E; Schmölzl C; Matrai A; Schramm W
    Contraception; 1989 Nov; 40(5):571-80. PubMed ID: 2692965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F; Ricci C; Fioretti P
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives, anti-thrombin III and fibrinolytic activity in Africans.
    Greig HB
    Acta Haematol; 1977; 58(3):138-44. PubMed ID: 409028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
    Kelleher CC
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic impact of oral contraceptives.
    Krauss RM; Burkman RT
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference limits of plasma fibrinogen.
    Tarallo P; Henny J; Gueguen R; Siest G
    Eur J Clin Chem Clin Biochem; 1992 Nov; 30(11):745-51. PubMed ID: 1489846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.